Latest hepatitis News | Page 2

WHO calls on global community to equalize HIV response
Progress and pathway towards elimination of cervical cancer among women living with HIV
Zimbabwe is first country in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
WHO announces update of Consolidated Guidelines on HIV Testing Services
WHO issues new framework to strengthen collaborative action on TB and comorbidities
Associate Professor Jessica Howell is VCCC Alliance’s inaugural Tony Burgess medallist
WHO and partners launch new online resource to advance STI vaccine development
WHO releases new module of PrEP implementation tool on integration of STI services
STIs in 2022: emerging and re-emerging outbreaks
Professor Jacob George’s vision for liver cancer
Dr Alisa Pedrana is Gust-McKenzie Medalist
WHO publishes new guidelines on HIV, hepatitis and STIs for key populations
WHO and UNAIDS support countries to introduce virtual interventions and HIV self-testing
WHO recommends long-acting cabotegravir for HIV prevention
NSW new hepatitis can’t wait
Kiwis urged to ‘Stick it to hep C’ with launch of national hepatitis C awareness campaign
HIV response under threat – new figures
WHO launched new implementation guidance for simplified and differentiated service delivery of pre-exposure prophylaxis
New Public Health services to improve health for all Kiwis
WHO publishes updated guidance on hepatitis C infection
NSW latest towards elimiation of hepatitis C as public health concern
World Hepatitis Summit 2022 statement
Seventy-fifth World Health Assembly noted 2022-2030 Global Health Sector Strategy on HIV, hepatitis and STIs
Burnet Institute partners with Moderna to develop novel mRNA vaccines
Integrating HIV and mental health services for better overall health
New funding for hepatitis campaigns
New guidelines from WHO recommend simpler, safer treatment for cryptococcal disease in people living with HIV
Blood-borne viruses on increase
One-dose Human Papillomavirus vaccine offers solid protection against cervical cancer
Accessible care key to treating hep C in people who inject drugs
QuickStart to treatment for hepatitis C
Covid pop-up vaccination clinics to open over school holidays
Boosters highly effective against COVID hospitalization, death
Insights to inform influenza health worker vaccination programmes
Zero Discrimination Day, 1 March 2022
NYU Research Competes in STAT Madness 2022
Cell research on rare disease finds new link to inflammation
Healthy Canberra Grants focus on reducing harm from risky behaviour
UN experts call for urgent repatriation of seriously ill woman from Syria camp: Canada
COVID jabs for juniors start today
US FDA approved cabotegravir extended-release – first long-acting injectable option for HIV pre-exposure prophylaxis
Australian childhood vaccination remains at record levels
Hepatitis NSW – 30 Years of Support and Service to Viral Hep Community
Call to accelerate study of new drugs for HIV in pregnant and breastfeeding women
$50 million investment in support for HIV and blood borne viruses
WHO publishes updated guidance on validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis
Sinead Sheils wins 2021 Hepatitis NSW Cheryl Burman Award
Biotron’s BIT225 effective against Covid in animal study